PRS6 A CANADIAN COST ANALYSIS OF 4 RANDOMIZED DOUBLEBLIND ACTIVE COMPARATOR TRIALS WITH TELITHROMYCIN IN ACUTE EXACERBATION OF CHRONIC BRONCHITIS (AECB) AND COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Abstract
Authors
E Tsakonas J Stewart J Chang